GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » OCI (XKRX:456040) » Definitions » Total Tax Payable

OCI (XKRX:456040) Total Tax Payable : ₩5,424 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OCI Total Tax Payable?

OCI's Total Tax Payable for the quarter that ended in Mar. 2024 was ₩5,424 Mil.

OCI's quarterly Total Tax Payable declined from Sep. 2023 (₩5,803 Mil) to Dec. 2023 (₩503 Mil) but then increased from Dec. 2023 (₩503 Mil) to Mar. 2024 (₩5,424 Mil).

OCI's annual Total Tax Payable stayed the same from . 20 (₩0 Mil) to . 20 (₩0 Mil) but then increased from . 20 (₩0 Mil) to Dec. 2023 (₩503 Mil).


OCI Total Tax Payable Historical Data

The historical data trend for OCI's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OCI Total Tax Payable Chart

OCI Annual Data
Trend Dec23
Total Tax Payable
502.75

OCI Quarterly Data
Jun23 Sep23 Dec23 Mar24
Total Tax Payable 3,456.41 5,803.39 502.75 5,423.99

OCI Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


OCI Total Tax Payable Related Terms

Thank you for viewing the detailed overview of OCI's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


OCI (XKRX:456040) Business Description

Traded in Other Exchanges
N/A
Address
94, Sogong-ro, Jung-gu, Seoul, KOR, 100-718
OCI is engaged in Solar PV Business, ESS (Energy Storage System), Cogeneration, Urban development projects, and Pharmaceutical-Bio business. The company will operate in Korea, China, and the United States.

OCI (XKRX:456040) Headlines

No Headlines